Instructions for Ergoferon
Ergoferon - homeopathic combined immunomodulatory drug; possesses antiviral, antihistamine, anti-inflammatory activity. Release form and composition
Dosage forms Ergoferon:
lozenges: from almost white to white, flat-cylindrical, with a bevel, on one side there is an inscription ERGOFERON, on the other - a dividing line and the inscription MATERIA MEDICA (20 pcs. in blisters, in a cardboard box 1, 2 or 5 packages); oral solution: a transparent almost colorless or colorless liquid (100 ml in an orange glass bottle with a dropper, in a cardboard box 1 bottle).
Pharmacological Ergoferon:
properties Pharmacodynamics is an immunomodulatory drug with antiviral, anti-inflammatory and antihistamine activity. A wide range of pharmacological action is due to its combined composition. All active components of the drug have the same mechanism of action, which consists in increasing the functional activity of the CD4 receptor, receptors for interferon gamma and histamine. This contributes to the pronounced immunotropic effect of Ergoferon
Pharmacokinetics Ergoferon:
It is technically impossible to study the pharmacokinetics of due to the insufficient sensitivity of modern physicochemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, chromatography-mass spectrometry), which does not allow a reliable assessment of the content of active components of the drug in tissues, organs and biological fluids of a person.
Indications for use Ergoferon:
According to the instructions, is recommended for the prevention and treatment of the following diseases: influenza virus type A and B; acute respiratory viral infections caused by adenovirus, parainfluenza virus, coronavirus, respiratory syncytial virus; herpesvirus infections (chickenpox, ophthalmic herpes, labial herpes, herpes zoster, genital herpes, infectious mononucleosis); acute intestinal infections caused by adenovirus, calicivirus, coronavirus, enterovirus, rotavirus; meningitis (enterovirus and meningococcal); hemorrhagic fever with renal syndrome; tick-borne viral encephalitis. In addition, the drug is prescribed as part of the complex therapy of whooping cough, pseudotuberculosis, pneumonia of various etiologies (including Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella speciales), and bacterial yersiniosis. And also for the prevention of superinfections and the prevention of bacterial complications of viral infections.
Contraindications Ergoferon:
The use of Ergoferon is contraindicated in patients with hypersensitivity to its components. The drug should be prescribed with caution during pregnancy and breastfeeding. Additional contraindications: tablets: congenital galactosemia or lactase deficiency, glucose-galactose malabsorption syndrome; solution: hereditary fructose intolerance, age up to 3 years. The solution must be taken with caution in patients with diabetes mellitus.
Side effects Ergoferon:
Taking Ergoferon can cause the development of hypersensitivity reactions.
special instructions Ergoferon:
In case of signs of side effects, you should consult a doctor. The content of maltitol in 5 ml of the solution is 0.3 g, which corresponds to 0.02 XE (bread unit). For the metabolism of maltitol in diabetes mellitus, it is necessary to consider the issue of adjusting the dose of insulin. When prescribing a dose of insulin, one should take into account the slow hydrolysis and absorption of the drug in the gastrointestinal tract.
Energy value of 5 ml of solution - 1.37 kcal. The energy value of maltitol is much lower than that of sucrose and amounts to 2.4 kcal / g. Influence on the ability to drive vehicles and complex mechanisms Taking tablets does not affect the patient's ability to drive vehicles and mechanisms. The effect of the solution on the psychophysical state of patients has not been studied.
1. Antiviral Activity of Ergoferon against Group A Rotavirus
2. Efficacy and safety of Ergoferon versus oseltamivir: Reply to the Letter to the Editor
3. Retraction: Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice
4. Ergoferon Increases IL-2 Production by Activated Lymphocytes